Most Patients with Cancer Involve Family in Treatment Decisions

Share this content:
Most lung and colorectal cancer patients involve family members in treatment decisions, with substantial variation by race/ethnicity and language.
Most lung and colorectal cancer patients involve family members in treatment decisions, with substantial variation by race/ethnicity and language.

Most lung and colorectal cancer patients involve family members in treatment decisions, with substantial variation by race/ethnicity and language, according to a study published in Cancer.

Gabriela S. Hobbs, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the extent and predictors of involvement of a patient's family in decisions regarding cancer treatment.

Data were collected for 5,284 patients with newly diagnosed lung and colorectal cancer from the Cancer Care Outcomes Research and Surveillance Consortium.

The researchers found that 1.5 percent of participants reported family-controlled decisions, with the highest adjusted rates observed among non-English-speaking Asians (12.8 percent).

Among the remaining patients, 49.4 percent reported equally sharing decisions with family, while 22.1 and 28.5 percent reported some and little family input, respectively. Patients who were married, female, older, and insured more frequently reported equally shared decisions with family, in adjusted analyses.

RELATED: Family Conflict Can Cause Cancer Surgery Recovery Complications

Family involvement varied by race/ethnicity and language; Chinese-speaking Asian and Spanish-speaking Hispanic patients equally shared decisions with family more often than white patients (59.8 and 54.8, respectively, versus 47.6 percent).

Even after adjustment for marital status and social support, Veterans Affairs patients were least likely to report sharing decisions with family.

"Further studies are needed to determine the impact of family involvement in treatment decisions on outcomes; until then, physicians should consider eliciting patients' preferences for family involvement," the authors write.

One author disclosed financial ties to consulting firms.

Reference

  1. Hobbs, Gabriela S., MD, et al. "The role of families in decisions regarding cancer treatments." Cancer. DOI: 10.1002/cncr.29064. February 23, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters